Maribavir Impurity 3
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

176299-71-1Maribavir Impurity 3

● In Stock

Catalogue No.:VE0028048
CAS No.:176299-71-1
Mol. Formula:C13H18O9
Mol. Weight:318.28 g/mol

Additional information on CAS 176299-71-1

Parent drug

Maribavir

IUPAC Name

(3S,4S,5S)-5-(Acetoxymethyl)tetrahydrofuran-2,3,4-triyl triacetate

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

CC(OC1[C@@H](OC(C)=O)[C@H]([C@H](COC(C)=O)O1)OC(C)=O)=O

InChI

InChI=1S/C13H18O9/c1-6(14)18-5-10-11(19-7(2)15)12(20-8(3)16)13(22-10)21-9(4)17/h10-13H,5H2,1-4H3/t10-,11-,12-,13?/m0/s1

Description

Maribavir Impurity 3 (CAS 176299-71-1) is a process-related and/or degradation impurity observed during synthesis and stability of maribavir. It requires comprehensive identification and quantification to establish impurity profiles and control strategies. Analytical characterization typically employs HPLC, LC-MS and NMR to determine retention behavior, exact mass and structural elucidation. Understanding formation pathways helps optimize synthetic steps and formulation conditions to minimize levels. Specifications should be set in line with ICH Q3A and Q3B limits with validated methods for detection at trace levels. Batch release and stability testing include targeted monitoring to ensure safety and product quality.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url